dc.contributor.author | Akgül, Özer | |
dc.contributor.author | Sapmaz, Burcu | |
dc.contributor.author | Çatal, Fadimana | |
dc.contributor.author | Çalışkan, Reyhan | |
dc.contributor.author | Yüksel, Pelin | |
dc.contributor.author | Öner, Yaşar Ali | |
dc.contributor.author | Aygün, Gökhan | |
dc.date.accessioned | 2019-06-25T10:07:00Z | |
dc.date.available | 2019-06-25T10:07:00Z | |
dc.date.issued | 2018-03 | |
dc.identifier.issn | 1300-932X | |
dc.identifier.uri | http://hdl.handle.net/20.500.12474/51 | |
dc.description.abstract | Clostridium difficile is a gram-positive, obligatory anaerobe, spore-forming microorganism, which is highly associated with nosocomial infections. In our hospital and our country, the incidence of nosocomial diarrhoea and C. difficile-associated nosocomial diarrhoea rates are not clear. Determining the C. difficile-associated nosocomial diarrhoea incidence, reviewing the current resistance status of C. difficile, and evaluating diagnostic and therapeutic approaches for this pathogen were the major aims of the present study. | tr_TR |
dc.language.iso | en | tr_TR |
dc.publisher | FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | tr_TR |
dc.subject | Nosocomial diarrhoea | tr_TR |
dc.subject | Clostridium difficile-associated diarrhoea | tr_TR |
dc.subject | Antibiotic resistance | tr_TR |
dc.title | Is the Incidence of Clostridium difficile in Nosocomial Diarrhoea Underestimated? | tr_TR |
dc.type | Article | tr_TR |